Table 3. Univariate and multivariate cox analysis for factors associated with overall survival for hepatocellular carcinoma patients treated by radiofrequency ablation (RFA) or transarterial chemoembolization (TACE) (n = 122).
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| P | Hazard ratio (95%CI) | P | Hazard ratio (95%CI) | |
| Age (years) | 0.922 | 0.998 (0.973-1.024) | ||
| Sex (Male) (%) | 0.727 | 0.891 (0.468-1.696) | ||
| BMI | 0.097 | 0.952 (0.899-1.008) | ||
| Platelet count (<100G/L) | 0.119 | 1.537 (0.895 -2.640) | ||
| Non-Viral hepatitis | 0.527 | 1.122 (0.656-2.274) | ||
| AFP>100 ng/ml | 0.049 | 1.799 (1.00 -3.230) | ||
| HCC>3cm | 0.641 | 1.138 (0.660-1.963) | ||
| Multiple nodules | 0.019 | 1.987 (1.122-3.519) | 0.006 | 2.257 (1.261-4.039) |
| Primary treatment failure | <0.001 | 3.641 (1.853-7.154) | <0.001 | 4.163 (2.088-8.298) |
| TACE (vs RFA) | 0.045 | 1.746 (1.012-3.012) | ||
Abbreviations: BMI= Body Mass Index; ALT= Alanine Amino Transferase; AFP= Alpha-Foeto-protein; HCC= HepatoCellular Carcinoma; RFA= Radiofrequency ablation; TACE= transarterial chemoembolization.